Showing results (231-240 of 1,479) with videos related to
Sort By:
Pageof 148
Human Psychopharmacology|June 4, 2010
Impact of serotonin receptor 2A gene haplotypes on C-peptide levels in clozapine- and olanzapine-treated patientsKristina I Melkersson, Arzu Gunes, Marja-Liisa DahlHuman Psychopharmacology|November 30, 2006
Survey of medication adherence in patients with schizophrenia--Korean ADHES dataSung-Wan Kim, Jin-Sang Yoon, Sung-Ku ChoiHuman Psychopharmacology|March 6, 2007
Atypical antipsychotics and polydipsia: a cause or a treatment?Giuseppe Bersani, Lorenzo Pesaresi, Valerio Orlandi, et al.Human Psychopharmacology|June 21, 2007
Tardive dyskinesia and glucid metabolismGeorges Brousse, Alexandre Meary, Jacques Mouret, et al.Human Psychopharmacology|June 15, 2007
Dissociation between objective psychomotor impairment and subjective sleepiness after diazepam administration in the aged peopleMasaru Echizenya, Kazuo Mishima, Kohtoku Satoh, et al.Human Psychopharmacology|June 29, 2007
Long-term administration of the low-dose risperidone in schizotaxia subjectsJanusz K Rybakowski, Wiktor Drozdz, Alina BorkowskaHuman Psychopharmacology|October 1, 2009
Remission in schizophrenia: one-year Italian prospective study of risperidone long-acting injectable (RLAI) in patients with schizophrenia or schizoaffective disorderAlessandro Rossi, Anna Bagalà, Vincenzo Del Curatolo, et al.Human Psychopharmacology|August 21, 2009
Cannabis and anxiety: a critical review of the evidenceJosé Alexandre Crippa, Antonio Waldo Zuardi, Rocio Martín-Santos, et al.Human Psychopharmacology|June 4, 2011
Association between plasma paroxetine concentration and changes in plasma brain‐derived neurotrophic factor levels in patients with major depressive disorderNorio Yasui-Furukori, Shoko Tsuchimine, Taku Nakagami, et al.Human Psychopharmacology|January 14, 2012
Medication attitudes and beliefs in patients with psychotic and affective disorders on maintenance treatmentChee Hong Ng, Deidre J Smith, Joel King, et al.Pageof 148